JP2023522078A5 - - Google Patents

Info

Publication number
JP2023522078A5
JP2023522078A5 JP2022563189A JP2022563189A JP2023522078A5 JP 2023522078 A5 JP2023522078 A5 JP 2023522078A5 JP 2022563189 A JP2022563189 A JP 2022563189A JP 2022563189 A JP2022563189 A JP 2022563189A JP 2023522078 A5 JP2023522078 A5 JP 2023522078A5
Authority
JP
Japan
Prior art keywords
group
formula
compound represented
methyl
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022563189A
Other languages
English (en)
Japanese (ja)
Other versions
JP7693709B2 (ja
JP2023522078A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/089660 external-priority patent/WO2021218863A1/zh
Publication of JP2023522078A publication Critical patent/JP2023522078A/ja
Publication of JP2023522078A5 publication Critical patent/JP2023522078A5/ja
Application granted granted Critical
Publication of JP7693709B2 publication Critical patent/JP7693709B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022563189A 2020-04-26 2021-04-25 1,5-ジヒドロ-2,4-ベンゾジアゼピン-3-オン誘導体及びその使用 Active JP7693709B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202010330893 2020-04-26
CN202010330893.1 2020-04-26
CN202110288141 2021-03-17
CN202110288141.8 2021-03-17
PCT/CN2021/089660 WO2021218863A1 (zh) 2020-04-26 2021-04-25 1,5-二氢-2,4-苯二氮䓬-3-酮衍生物及其应用

Publications (3)

Publication Number Publication Date
JP2023522078A JP2023522078A (ja) 2023-05-26
JP2023522078A5 true JP2023522078A5 (https=) 2024-04-11
JP7693709B2 JP7693709B2 (ja) 2025-06-17

Family

ID=78374068

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022563189A Active JP7693709B2 (ja) 2020-04-26 2021-04-25 1,5-ジヒドロ-2,4-ベンゾジアゼピン-3-オン誘導体及びその使用

Country Status (9)

Country Link
US (1) US12559471B2 (https=)
EP (1) EP4144725B1 (https=)
JP (1) JP7693709B2 (https=)
KR (1) KR102832951B1 (https=)
CN (1) CN115667236B (https=)
AU (1) AU2021262281B2 (https=)
BR (1) BR112022021228A2 (https=)
CA (1) CA3172692C (https=)
WO (1) WO2021218863A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115605202B (zh) 2020-03-26 2025-10-28 盐野义制药株式会社 具有血清素受体结合活性的芳香族杂环衍生物
CN121039114A (zh) 2023-04-21 2025-11-28 江苏恩华药业股份有限公司 1,5-二氢-2,4-苯二氮䓬-3-酮衍生物枸橼酸盐的晶型、制备方法及其应用
WO2025044768A1 (zh) * 2023-08-29 2025-03-06 江苏恩华药业股份有限公司 1,5-二氢-2,4-苯二氮䓬-3-酮衍生物的制备方法和其中间体及其制备方法
CN120329280A (zh) * 2024-01-17 2025-07-18 江苏恩华药业股份有限公司 取代的1,2,4-四氢-3h-苯并二氮䓬-3-酮衍生物及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60161986A (ja) * 1983-12-24 1985-08-23 Nippon Soda Co Ltd イミダゾ(1,5−a)ピリジン−3−オン誘導体及びその製造方法
ES2197160T3 (es) * 1992-12-21 2004-01-01 Smithkline Beecham Corp Antagonistas fibronogeno bicicliclos.
EP0960104B1 (en) * 1996-04-17 2004-06-16 Bristol-Myers Squibb Pharma Company N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors
UA60311C2 (uk) * 1996-10-02 2003-10-15 Смітклайн Бічам Корпорейшн Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція
GT199800109A (es) * 1997-08-06 2000-01-13 Derivados de n-sulfonilglicinalquiniloxifenetilamida microbicidas.
JP2003503476A (ja) * 1999-07-06 2003-01-28 バーテックス ファーマシューティカルズ インコーポレイテッド 環化アミド誘導体
SI1720836T1 (sl) * 2004-02-25 2014-06-30 Eli Lilly And Company 6-substituirani 2,3,4,5-tetrahidro-1h-benzo (d)azepini kot agonisti 5-ht2c receptorja
KR101594898B1 (ko) 2005-07-15 2016-02-18 알바니 몰레큘라 리써치, 인크. 아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도
US7473778B2 (en) * 2005-12-24 2009-01-06 Boehringer Ingelheim International Gmbh 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-one
US20100222326A1 (en) 2007-04-27 2010-09-02 Ucb Pharma, S.A. New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
JP5502733B2 (ja) * 2007-07-26 2014-05-28 エフ.ホフマン−ラ ロシュ アーゲー 5−ht2a及びd3受容体の二重のモジュレーター
US9309200B2 (en) * 2011-05-12 2016-04-12 AbbVie Deutschland GmbH & Co. KG Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
EP3409658B9 (en) * 2016-01-29 2024-07-17 ONO Pharmaceutical Co., Ltd. Tetrahydronaphthalene derivative

Similar Documents

Publication Publication Date Title
JP2023522078A5 (https=)
JP7693709B2 (ja) 1,5-ジヒドロ-2,4-ベンゾジアゼピン-3-オン誘導体及びその使用
US10105359B2 (en) Tetrahydroisoquinoline derivatives
TW200911254A (en) Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators-842
US11345666B2 (en) Phenyl and pyridinyl substituted imidazoles as modulators of RORγT
JP2017524005A (ja) オレキシンレセプターモジュレーターとしてのジフルオロピロリジン
KR20150082616A (ko) 디히드로피라졸 gpr40 조절제
JP7746259B2 (ja) 核内受容体に対して活性の化合物
JP4897683B2 (ja) チエノピリジノン化合物及び治療方法
JP2016504282A (ja) ジヒドロピラゾールgpr40モジュレーター
CN102639513A (zh) 鞘氨醇激酶抑制剂
WO2023278686A1 (en) Spirocyclic pyridine-1,5-diones exhibiting mnk inhibition and their method of use
CA2806051A1 (en) Cyclic n,n'-diarylthioureas and n,n'-diarylureas - androgen receptor antagonists, anticancer agent, method for preparation and use thereof
KR20060123452A (ko) 나프티리딘 유도체 및 무스카린 수용체의 조절자로서의이의 용도
CN116444484B (zh) 1,5-二氢-2,4-苯二氮䓬-3-酮衍生物的盐及应用
WO2023274280A1 (zh) 一种联苯类衍生物抑制剂的晶型及其制备方法
CN107459476A (zh) 反吲哚啉环丙胺类化合物及其制备方法、药物组合物和用途
CN108403698A (zh) 用于治疗细菌感染的方法和组合物
WO2014127722A1 (zh) 氮杂环取代二氢青蒿素衍生物及其应用
US10301286B2 (en) Piperazine derivative
EP2546255A1 (en) Benzazepine compound
JPWO2017183723A1 (ja) Kcnq2〜5チャネル活性化剤
US12600698B2 (en) Kinase inhibitors
HK40080583B (zh) 1,5-二氢-2,4-苯二氮䓬-3-酮衍生物及其应用
HK40080583A (en) 1,5-dihydro-2,4-benzodiazepine-3-one derivative and application thereof